🚀 BiFinance IPO Series | 天辰生物-B HK STOCK IPO 👉 As a biotechnology company focused on innovative drug development, 天辰生物-B is committed to creating globally best-in-class and first-in-class therapies for cancer and other serious diseases. 🧬 Biotech × HK Stock IPO 🌍 Bridging Traditional Finance and Web3 📈 IPO Price: 96.06 HKD ⏰ Subscription Starts: 2026/5/28 9:00 Innovation in biotechnology is accelerating toward global capital markets, reshaping the future of healthcare and finance. #BiFinance# #IPO# #HKStocks# #Biotech# #Web3#

China is following AI developments in the US very closely including recent news of AI designing new viruses. China's Science & Tech Daily headline: "AI generates functional viruses from scratch for the first time; the biosecurity risks posed by such technology cannot be ignored" AI首次从零生成功能性病毒，​此类技术带来的生物安全问题不容忽视

At Jiangxi Fudan Biotechnology Co., Ltd., 1 million fresh eggs are processed into 42 tons of standardized liquid egg raw materials daily, which are supplied to surrounding food enterprises, building an industrial chain featuring precise docking and efficient collaboration. 在江西福旦生物科技有限公司，每天有100万枚鲜蛋转化为42吨标准化蛋液原料，供往周边食品企业，形成精准对接、高效协同的产业链。 #China# #Jiangxi# #JiangxiEconomy# #世界经济看中国# #赣出新精彩#